Genetically engineered mouse models of neurodegenerative diseases (original) (raw)

• Price, D.L., Tanzi, R.E., Borchelt, D.R. & Sisodia, S.S. Alzheimer's disease: genetic studies and transgenic models. Annu. Rev. Genet. 32, 461–493 (1998).
  CAS PubMed Google Scholar
• Lee, V.M.Y. & Trojanowski, J.Q. Neurodegenerative taupathies: human disease and transgenic mouse models. Neuron 24, 507–510 (1999).
  CAS PubMed Google Scholar
• Lin, X., Cummings, C.J. & Zoghbi, H.Y. Expanding our understanding of polyglutamine diseases through mouse models. Neuron 24, 499–502 (1999).
  CAS PubMed Google Scholar
• Dunnett, S.B. & Bjorklund, A. Prospects for new restorative and neuroprotective treatments in Parkinson's Disease. Nature 399, A32–A39 (1999).
  CAS PubMed Google Scholar
• Yamamoto, A., Lucas, J.J. & Hen, R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 101, 57–66 (2000).
  CAS PubMed Google Scholar
• Hardy, J. & Gwinn-Hardy, K. Genetic classification of primary neurodegenerative disease. Science 282, 1075–1079 (1998).
  CAS PubMed Google Scholar
• Selkoe, D.J. Alzheimer's disease: genes, proteins and therapy. Physiol. Rev. 81, 741–766 (2001).
  CAS PubMed Google Scholar
• Price, D.L., Sisodia, S.S. & Borchelt, D.R. Genetic neurodegenerative diseases: the human illness and transgenic models. Science 282, 1079–1083 (1998).
  CAS PubMed Google Scholar
• Schilling, G. et al. Intranuclear inclusions and neuritic pathology in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum. Mol. Genet. 8, 397–407 (1999).
  CAS PubMed Google Scholar
• Goedert, M., Spillantini, M.G. & Davies, S.W. Filamentous nerve cell inclusions in neurodegenerative diseases. Curr. Opin. Neurobiol. 8, 619–632 (1998).
  CAS PubMed Google Scholar
• Zoghbi, H.Y. & Orr, H.T. Polyglutamine diseases: protein cleavage and aggregation. Curr. Opin. Neurobiol. 9, 566–570 (1999).
  CAS PubMed Google Scholar
• Albert, M.S. & Drachman, D.A. Alzheimer's disease. What is it, how many people have it, and why do we need to know? Neurology 55, 166–168 (2000).
  CAS PubMed Google Scholar
• Mesulam, M.M. Neuroplasticity failure in Alzheimer's disease: bridging the gape between plaques and tangles. Neuron 24, 521–529 (1999).
  CAS PubMed Google Scholar
• Price, D.L. & Sisodia, S.S. Mutant genes in familial Alzheimer's disease and transgenic models. Annu. Rev. Neurosci. 21, 479–505 (1998).
  CAS PubMed Google Scholar
• Beach, T.G. et al. The cholinergic deficit coincides with Aβ deposition at the earliest histopathologic stages of Alzheimer disease. J. Neuropathol. Exp. Neurol. 59, 308–313 (2000).
  CAS PubMed Google Scholar
• Serpell, L.C., Blake, C.C.F. & Fraser, P.E. Molecular structure of a fibrillar Alzheimer's Aβ fragment. Biochemistry 39, 13269–13275 (2000).
  CAS PubMed Google Scholar
• Lansbury, P.T. Jr. Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. Proc. Natl. Acad. Sci. USA 96, 3342–3344 (1999).
  CAS PubMed PubMed Central Google Scholar
• Tanzi, R.E. New frontiers in Alzheimer's disease genetics. Neuron 32, 181–184 (2001).
  CAS PubMed Google Scholar
• Selkoe, D.J. Clearing the brain's amyloid cobwebs. Neuron 32, 177–180 (2001).
  CAS PubMed Google Scholar
• Sinha, S. et al. Purification and cloning of amyloid precursor protein β-secretase from human brain. Nature 402, 537–540 (1999).
  CAS PubMed Google Scholar
• Hussain, I. et al. Identification of a novel aspartic protease (Asp 2) as β-secretase. Mol. Cell. Neurosci. 14, 419–427 (1999).
  CAS PubMed Google Scholar
• Lin, X. et al. Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein. Proc. Natl. Acad. Sci. USA 97, 1456–1460 (2000).
  CAS PubMed PubMed Central Google Scholar
• Yan, R. et al. Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity. Nature 402, 533–537 (1999).
  CAS PubMed Google Scholar
• Vassar, R. et al. β-secretase cleavage of Alzheimer's amyloid precusor protein by the transmembrane aspartic protease BACE. Science 286, 735–741 (1999).
  CAS PubMed Google Scholar
• Wong, P.C., Price, D.L. & Cai, H. The brain's susceptibility to amyloid plaques. Science 293, 1434–1435 (2001).
  CAS PubMed Google Scholar
• Farzan, M., Schnitzler, C.E., Vasilieva, N., Leung, D. & Choe, H. BACE2, a β-secretase homolog, cleaves at the β site and within the amyloid-β region of the amyloid-β precursor protein. Proc. Natl. Acad. Sci. USA 97, 9712–9717 (2000).
  CAS PubMed PubMed Central Google Scholar
• Nilsberth, C. et al. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation. Nat. Neurosci. 4, 887–893 (2001).
  CAS PubMed Google Scholar
• Sherrington, R. et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754–760 (1995).
  CAS PubMed Google Scholar
• Levy-Lahad, E. et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973–977 (1995).
  CAS PubMed Google Scholar
• Rogaev, E.I. et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775–778 (1995).
  CAS PubMed Google Scholar
• Thinakaran, G. et al. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17, 181–190 (1996).
  CAS PubMed Google Scholar
• Sisodia, S.S. & George-Hyslop, P.H. gamma-secretase, Notch, Aβ and Alzheimer's disease: where do the presenilins fit in? Nat. Rev. Neurosci. 3, 281–290 (2002).
  CAS PubMed Google Scholar
• Esler, W.P. & Wolfe, M.S. A portrait of Alzheimer secretases—new features and familiar faces. Science 293, 1449–1454 (2001).
  CAS PubMed Google Scholar
• Vassar, R. & Citron, M. Aβ-generating enzymes: recent advances in β- and γ-secretase research. Neuron 27, 419–422 (2000).
  CAS PubMed Google Scholar
• De Strooper, B. et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391, 387–390 (1998).
  CAS PubMed Google Scholar
• Wolfe, M.S. et al. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and secretase activity. Nature 398, 513–517 (1999).
  CAS PubMed Google Scholar
• Kopan, R. & Goate, A. Aph-2/Nicastrin: an essential component of gamma-secretase and regulator of notch signaling and presenilin localization. Neuron 33, 321–324 (2002).
  CAS PubMed Google Scholar
• Calhoun, M.E. et al. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc. Natl. Acad. Sci. USA 96, 14088–14093 (1999).
  CAS PubMed PubMed Central Google Scholar
• Chen, G. et al. A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease. Nature 408, 975–979 (2000).
  CAS PubMed Google Scholar
• Mucke, L. et al. High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20, 4050–4058 (2000).
  CAS PubMed PubMed Central Google Scholar
• Hsia, A.Y. et al. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. USA 96, 3228–3233 (1999).
  CAS PubMed PubMed Central Google Scholar
• Lewis, J. et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293, 1487–1491 (2001).
  CAS PubMed Google Scholar
• Götz, J., Chen, F., Barmettler, R. & Nitsch, R.M. Tau filament formation in transgenic mice expressing P301L tau. J. Biol. Chem. 276, 529–534 (2001).
  PubMed Google Scholar
• Borchelt, D.R. et al. Accelerated amyloid deposition in the brains of transgenic mice co-expressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19, 939–945 (1997).
  CAS PubMed Google Scholar
• Zheng, H. et al. β-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell 81, 525–531 (1995).
  CAS PubMed Google Scholar
• Heber, S. et al. Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. J. Neurosci. 20, 7951–7963 (2000).
  CAS PubMed PubMed Central Google Scholar
• Struhl, G. & Greenwald, I. Presenilin is required for activity and nuclear access of notch in drosophila. Nature 398, 522–525 (1999).
  CAS PubMed Google Scholar
• Wong, P.C. et al. Presenilin 1 is required for Notch1 and Dll1 expression in the paraxial mesoderm. Nature 387, 288–292 (1997).
  Article CAS PubMed Google Scholar
• Donoviel, D. et al. Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dev. 13, 2801–2810 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Yu, H. et al. APP processing and synaptic plasticity in presenilin-1 conditional knockout mice. Neuron 31, 713–726 (2001).
  CAS PubMed Google Scholar
• Feng, R. et al. Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces. Neuron 32, 911–926 (2001).
  CAS PubMed Google Scholar
• Cai, H. et al. BACE1 is the major β-secretase for generation of Aβ peptides by neurons. Nat. Neurosci. 4, 233–234 (2001).
  CAS PubMed Google Scholar
• Luo, Y. et al. Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation. Nature 4, 231–232 (2001).
  CAS Google Scholar
• Roberds, S.L. et al. BACE knockout mice are healthy despite lacking the primary β-secretase activity in brain: implication for Alzheimer's disease therapeutics. Hum. Mol. Genet. 10, 1317–1324 (2001).
  CAS PubMed Google Scholar
• Bodendorf, U., Fischer, F., Bodian, D., Multhaup, G. & Paganetti, P. A splice variant of β-secretase deficient in the amyloidogenic processing of the amyloid precursor protein. J. Biol. Chem. 276, 12019–12023 (2001).
  CAS PubMed Google Scholar
• Li, Y.M. et al. Photoactivated γ-secretase inhibitors directed to the active site convalently label presenilin 1. Nature 405, 689–693 (2000).
  CAS PubMed Google Scholar
• Huppert, S.S. et al. Embryonic lethality in mice homozygous for a processing-deficient allele of Notch 1. Nature 405, 966–970 (2000).
  CAS PubMed Google Scholar
• Petit, A. et al. New protease inhibitors prevent γ-secretase-mediated production of Aβ40/42 without affecting Notch clevage. Nat. Cell Biol. 3, 507–511 (2001).
  CAS PubMed Google Scholar
• Hadland, B.K. et al. γ-secretase inhibitors repress thymocyte development. Proc. Natl. Acad. Sci. USA 98, 7487–7491 (2001).
  CAS PubMed PubMed Central Google Scholar
• Bard, F. et al. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer's disease. Nat. Med. 6, 916–919 (2000).
  CAS PubMed Google Scholar
• Schenk, D. et al. Immunization with amyloid attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173–177 (1999).
  CAS PubMed Google Scholar
• DeMattos, R.B. et al. Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 98, 8850–8855 (2001).
  CAS PubMed PubMed Central Google Scholar
• Janus, C. et al. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408, 979–982 (2000).
  CAS PubMed Google Scholar
• Morgan, D. et al. A β peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408, 982–985 (2000).
  CAS PubMed Google Scholar
• Ince, P.G. in Amyotrophic Lateral Sclerosis (eds. Brown, R. H. Jr., Meininger, V. & Swash, M.) 83–112 (Martin Dunitz, London, 2000).
  Google Scholar
• Martin, L.J. Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism. J. Neuropathol. Exp. Neurol. 58, 459–471 (1999).
  CAS PubMed Google Scholar
• Andersen, P.M., Morita, M. & Brown, R.H. Jr. in Amyotrophic Lateral Sclerosis (eds. Brown, R. H. Jr., Meininger, V. & Swash, M.) 223–250 (Martin Dunitz, London, 2000).
  Google Scholar
• Cleveland, D.W. & Rothstein, J.D. From Charcot to Lou Gehrig: deciphering selective motor neurons death in ALS. Nature 2, 806–819 (2001).
  CAS Google Scholar
• Hadano, S. et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat. Genet. 29, 166–173 (2001).
  CAS PubMed Google Scholar
• Yang, Y. et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat. Genet. 29, 160–165 (2001).
  CAS PubMed Google Scholar
• Gurney, M.E. et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264, 1772–1775 (1994).
  CAS PubMed Google Scholar
• Wong, P.C. et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105–1116 (1995).
  CAS PubMed Google Scholar
• Bruijn, L.I. et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18, 327–338 (1997).
  CAS PubMed Google Scholar
• Jackson, M. & Rothstein, J.D. in Amyotrophic Lateral Sclerosis (eds. Brown, R. H. Jr., Meininger, V. & Swash, M.) 263–278 (Martin Dunitz, London, 2000).
  Google Scholar
• Shaw, P.J. in Amyotrophic Lateral Sclerosis (eds. Brown, R. H. Jr., Meininger, V. & Swash, M.) 113–144 (Martin Dunitz, London, 2000).
  Google Scholar
• Williamson, T.L. & Cleveland, D.W. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci. 2, 50–56 (1999).
  CAS PubMed Google Scholar
• Julien, J.-P. Amyotrophic lateral sclerosis: unfolding the toxicity of the misfolded. Cell 104, 581–591 (2001).
  CAS PubMed Google Scholar
• Pasinelli, P., Borchelt, D.R., Houseweart, M.K., Cleveland, D.W. & Brown, R.H. Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase. Neurobiology 95, 15763–15768 (1998).
  CAS Google Scholar
• Couillard-Després, S. et al. Protective effect of neurofilament NF-H overexpression in motor neuron disease induced by mutant superoxide dismutase. Proc. Natl. Acad. Sci. USA 95, 9626–9630 (1998).
  PubMed PubMed Central Google Scholar
• Klivenyi, P. et al. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat. Med. 5, 347–350 (1999).
  CAS PubMed Google Scholar
• Estévez, A.G. et al. Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science 286, 2498–2500 (1999).
  PubMed Google Scholar
• Wong, P.C. et al. Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase. Proc. Natl. Acad. Sci. USA 97, 2886–2891 (2000).
  CAS PubMed PubMed Central Google Scholar
• Subramaniam, J.R. et al. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading. Nat. Neurosci. 5, 301–307 (2002).
  CAS PubMed Google Scholar
• Johnston, J.A., Dalton, M.J., Gurney, M.E. & Kopito, R.R. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 97, 12571–12576 (2000).
  CAS PubMed PubMed Central Google Scholar
• Bruijn, L.I. et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281, 1851–1854 (1998).
  CAS PubMed Google Scholar
• Beaulieu, J.M., Jacomy, H. & Julien, J.P. Formation of intermediate filament protein aggregates with disparate effects in two transgenic mouse models lacking the neurofilament light subunit. J. Neurosci. 20, 5321–5328 (2000).
  CAS PubMed PubMed Central Google Scholar
• Eyer, J., Cleveland, D.W., Wong, P.C. & Peterson, A.C. Pathogenesis of two axonopathies does not require axonal neurofilaments. Nature 391, 584–587 (1998).
  CAS PubMed Google Scholar
• Williamson, T.L. et al. Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant. Proc. Natl. Acad. Sci. USA 95, 9631–9636 (1998).
  CAS PubMed PubMed Central Google Scholar
• Kong, J. & Xu, Z. Overexpression of neurofilament subunit NF-L and NF-H extends survival of a mouse model for amyotrophic lateral sclerosis. Neurosci. Lett. 281, 72–74 (2000).
  CAS PubMed Google Scholar
• Crawford, T. & Pardo, C.A. The neurobiology of childhood spinal muscular atrophy. Neurobiol. Dis. 3, 97–110 (1996).
  CAS PubMed Google Scholar
• Lefebvre, S. et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80, 155–165 (1995).
  CAS PubMed Google Scholar
• Roy, N. et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80, 167–178 (1995).
  CAS PubMed Google Scholar
• Fischer, U., Liu, Q. & Dreyfuss, G. The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis. Cell 90, 1023–1029 (1997).
  CAS PubMed Google Scholar
• Pagliardini, S. et al. Subcellular localization and axonal transport of the survival motor neuron (SMN) protein in the developing rat spinal cord. Hum. Mol. Genet. 9, 47–56 (2000).
  CAS PubMed Google Scholar
• Jablonka, S., Schrank, B., Kralewski, M., Rossoll, W. & Sendtner, M. Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: an animal model for spinal muscular atrophy type III. Hum. Mol. Genet. 9, 341–346 (2000).
  CAS PubMed Google Scholar
• Hsieh-Li, H.M. et al. A mouse model for spinal muscular atrophy. Nat. Genet. 24, 66–70 (2000).
  CAS PubMed Google Scholar
• Monani, U.R. et al. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn−/− mice and results in a mouse with spinal muscular atrophy. Hum. Mol. Genet. 9, 333–339 (2000).
  CAS PubMed Google Scholar
• Chang, J.-G. et al. Treatment of spinal muscular atrphy by sodium butyrate. Proc. Natl. Acad. Sci. USA 98, 9808–9813 (2001).
  CAS PubMed PubMed Central Google Scholar